Hypertrophic Cardiomyopathy: Causes, Treatment and Research

Ikram Kammoun (Editor)
Ariana Hospital, University ElManar, Tunis, Tunisia

Series: Cardiology Research and Clinical Developments
BISAC: MED010000

Clear

$95.00

Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick

eBook

Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:

Quantity:

Details

Hypertrophic cardiomyopathy (HCM) is the most common form of genetically inherited cardiovascular disease, with a prevalence of one in 500 individuals. Hypertrophic cardiomyopathy is characterized by both increased ventricular wall thickness in the absence of other causative conditions and potentially fatal arrhythmias. Tunisian authors, together with recognized specialists in this field from Italy, France, and Austria, offer a broad and detailed discussion of diagnosis, risk stratification and management of HCM. This book describes recent advances in genetics which provide screening options for affected families, making it essential for modern cardiologists to understand the diagnostic, therapeutic, and prognostic implications of HCM genetic testing. The diagnostic and prognostic role of cardiac imaging in HCM, with reference to echocardiography and cardiac magnetic resonance, is detailed within this book as well. The greatest challenge in the management of HCM is identifying individuals who are at an increased risk of sudden cardiac death. This book offers an overview of the most recent data available concerning this stratification. The obstructive form of HCM is also dealt with in this book with a description of the different catheter-based techniques for septal reduction.

Finally, the topic of management of pregnant women with HCM is addressed. (Imprint: Nova Biomedical)

Introduction

Chapter 1. Recent Advances in Genetic Testing for Hypertrophic Cardiomyopathy (pp. 1-28)
Sinda Zarrouk-Mahjoub, Josef Finsterer, Mouna HadjBrahim and Ikram Kammoun

Chapter 2. Focus on Diagnosis in Hypertrophic Cardiomyopathy (pp. 29-56)
Leila Abid and Salma Charfeddine

Chapter 3. Atrial Fibrillation in Hypertrophic Cardiomyopathy (pp. 57-72)
Françoise Hidden-Lucet and Estelle Gandjbakhch

Chapter 4. Mitral Valve Abnormalities Identified by Cardiac Magnetic Resonance in Patients with Hypertrophied Cardiomyopathy (pp. 73-82)
Henda Neji, Monia Attia, Saoussen Hantous-Zannad, Ines Baccouche and Khaoula Ben Miled M’rad

Chapter 5. Echocardiographic Predictors of Unfavourable Outcome in Hypertrophic Cardiomyopathy (pp. 83-104)
Ikram Kammoun, Sonia Marrakchi, Emna Bennour and Salem Kachboura

Chapter 6. Risk Stratification of Sudden Cardiac Death in Hypertrophic Cardiomyopathy (pp. 105-146)
Sonia Marrakchi, Ikram Kammoun, Emna Bennour, Françoise Hidden Lucet and Salem Kachboura

Chapter 7. Catheter-Based Techniques for Septal Reduction in Obstructive Hypertrophic Cardiomyopathy (pp. 147-164)
Marouane Boukhris, Salvatore D. Tomasello, Alfredo R. Galassi and Salem Kachboura

Chapter 8. Hypertrophic Cardiomyopathy and Pregnancy (pp. 165-178)
Emna Bennour, Ikram Kammoun, Sonia Marrakchi and Salem Kachboura

Index (pp. 179)

You have not viewed any product yet.